Fundraising Fox

Beren

110 employees on LinkedIn · 5 known investors

Beren is a public benefit corporation developing novel medicines in partnership with patients, caregivers, clinicians, and health systems. It focuses on advancing biology and chemistry to address the root causes of diseases.

Founders & leadership

JCJason Camm
Jason CamminFounder, President & Chief Executive OfficerInvestor at Thiel Capital
AOAaron Ondrey
Aaron OndreyinChief Financial Officer
AGAlex Gold
Alex GoldinChief Medical Officer
JSJennifer Spinella
Jennifer SpinellainChief Regulatory Officer & Head of Quality
IVIrene von Hennigs
Irene von HennigsinSVP, Global Medical Affairs
BSBennett Smith
Bennett SmithinSVP, Commercial
RSRajinder Singh
Rajinder SinghinChief Scientific Officer
MHMagali Hickey
Magali HickeyinSVP, Technical Operations and CMC
HMHeather McCuen
Heather McCueninChief People Officer
PCPeter Cicala
Peter CicalainGeneral Counsel and Head of Intellectual Property and Innovation

Investors · 5

Competitors · 1

by search overlap

Companies competing with Beren for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Beren do?
Beren is a public benefit corporation developing novel medicines in partnership with patients, caregivers, clinicians, and health systems. It focuses on advancing biology and chemistry to address the root causes of diseases.
Who founded Beren?
Beren was founded by Jason Camm.
Who are Beren's investors?
Beren's investors include Alpha Wave Global, Eisai Innovation, Inc., Narya Capital, Octave Ventures Llc, UTokyo Innovation Platform Co. Ltd..